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Conclusions: Patients undergoing secondary interventions for recur-
rent RAS have comparable outcomes as those for primary interventions.
These data suggest that repeated endovascular procedures for renal artery
restenosis can be safely undertaken while maintaining similar expectations
for clinical improvement.
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Introduction and objectives: Although computed tomography an-
giography (CTA) is commonly used preoperatively to determine arterial anat-
omy, duplex ultrasound (DUS) vein mapping is frequently used to determine
the suitability of bypass conduits. The purpose of this study was to determine the
correlation between DUS and CTA in the evaluation of the great saphenous
vein (GSV) with respect to diameter and usability in lower extremity bypasses.
Methods: A single-center retrospective review identified patients who
had both CTA and DUS in preparation for lower extremity bypass, between
June 2001 and February 2012. DUS reports included GSV diameter at the
saphenofemoral junction, midthigh, knee, and midcalf. CTAs were reviewed
independently by two vascular surgeons who were blinded to the DUS and
surgical findings. The interobserver variability was analyzed using Pearson
correlation. The relationship between CTA and DUS measurements was
compared at each anatomic level using correlation coefficients. The predic-
tive ability of CTA was analyzed using the Fisher exact test.
Results: Sixteen patients (9 men [56.3%]) underwent CTA and DU in
preparation for lower extremity bypass (23 limbs). The average patient age
was 65.1 years, 10 (62.5%) were diabetic, and three (18.8%) had a history of
DVT or phlebitis. A high degree of correlation existed between the two
surgeons’ GSV measurements using CTA (r  .09996, P  .0001), and a
strong correlation existed between CTA and DUS GSV measurements (r
.07306, P .0001). CTA assessment of GSV usability correlates with actual
usage as conduit (P .0099) with a sensitivity of 92% and sensitivity of 80%.
Conclusions:CTA can be accurately used to evaluate the diameter and
usability of the GSV for lower extremity revascularization, eliminating the
need for additional testing.
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Introduction and objectives: Patients with class 4 and 5 chronic kidney
disease (CKD) and peripheral vascular disease (PVD) are at increased risk of
major adverse limb events (MALE), amputation, and death. We evaluated the
effect of CKD on outcomes after peripheral vascular intervention (PVI).
Methods: All primary PVIs performed at a single institution (January
2002-December 2009) were included. End points were defined by Society
for Vascular Surgery (SVS) objective performance goals for critical limb
ischemia (J Vasc Surg 2009;50:1462-73): death, reintervention, amputa-
tion, death/amputation, and MALE (reintervention or amputation).
Results: A total of 879 PVIs were performed, with CKD in 125
(14%). CKD patients were significantly (P  .05) more likely to have
diabetes (64% vs 46%), critical ischemia (72% vs 11%), multilevel PVI
(34% vs 19%), and tibial intervention (35% vs 20%). Distribution of
Trans-Atlantic Inter-Society Consensus C and D lesions were similar
(19% CKD vs 15%; P  .02). CKD was not associated with SVS high-risk
criteria (age 80 years and CLI; 14% CKD vs 11%; P  .3). CKD
predicted 30-day reintervention (odds ratio [OR], 2.3; confidence inter-
val [CI], 1.5-4; P  .005), amputation/death (OR, 3.1; CI, 1.1-9; P 
.004), and MALE (OR, 2.8; CI, 1.3-6.1; P  .004) independent of CLI.
On Cox regression, CKD increased late death (HR, 2.4; CI, 1.8-3.2; P
.01), amputation (HR, 2.1; CI, 1.1-3.9; P  .002), and death/amputa-
tion (HR, 1.8; CI, 1.3-2.4; P  .004), with no increase in reintervention
or MALE. On Kaplan-Meier analysis, CKD was significantly (log-rank,
P  .05) associated with death (31%  4% vs 7%  1%), amputation
(14%  3% vs 3%  1%), death/amputation (31%  4% vs 9%  1%), and
MALE (40%  5% vs 26%  2%) at 1 year. Freedom from reintervention
was similar at 1 year (70%  5% severe CKD vs 75%  2%; P  .23).
Conclusions: Current performance goals have excluded patients with
severe CKD, yet CKD independently predicts early and late adverse events
after PVI, in particular, excessive mortality. CKD should figure prominently
in clinical decision making for patients with PVD.
Long-Term Durability of Endovascular and Open Revascularization
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Introduction and objectives: To compare clinical outcomes and
long-term durability of aortoiliac (AI) and femoropopliteal (FP) endovascu-
lar (EV) and open interventions for disabling claudication (DC), and to
determine the effect of Trans-Atlantic Inter-Society Consensus (TASC
classification (A/B vs C/D) on outcomes.
Methods: Patients with Rutherford 3 DC, who had open (n 
93,107 limbs), or EV interventions (n  167, 206 limbs) between June
2001 and December 2009 were grouped as AI open (n  47), AI
EV-A/B (n 91), AI EV-C/D (n 35), FP open (n 60), FP EV-A/B
(n  29), and FP EV-C/D (n  51). Patency, sustained clinical success
(clinical improvement, freedom from target extremity revascularization),
and secondary clinical success (with target extremity revascularization)
were calculated.
Results: There were more smokers (79% vs 57%, P  .001) and less
diabetes mellitus (25% vs 37%, P  .003) in open and less CAD in FP
EV-A/B (24% vs 50%, P  .0009). Mean follow-up was 48  24 months.
Patency and clinical success rates were similar in iliac subgroups (Table). FP
EV-C/D and FP open groups fared significantly worse than FP EV-A/B. In AI,
9% in open and 15% in EV groups had reinterventions; 1% (n  2) needed
bypass. In FP EV-A/B, 17% needed reinterventions, 3% had bypass; in FPFig.
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